Sumitomo Mitsui Trust Group
WST icon

Sumitomo Mitsui Trust Group’s West Pharmaceutical WST Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Sell
168,080
-4,700
-3% -$1.44M 0.03% 407
2026
Q1 		$43.3M Sell
172,780
-3,336
-2% -$830K 0.03% 480
2025
Q4 		$48.5M Sell
176,116
-12,379
-7% -$3.39M 0.03% 477
2025
Q3 		$49.4M Sell
188,495
-3,148
-2% -$765K 0.03% 476
2025
Q2 		$41.9M Buy
191,643
+13,446
+8% +$2.87M 0.03% 499
2025
Q1 		$39.9M Sell
178,197
-1,172
-0.7% -$323K 0.03% 501
2024
Q4 		$58.8M Buy
179,369
+1,786
+1% +$562K 0.04% 413
2024
Q3 		$53.3M Sell
177,583
-224
-0.1% -$68.6K 0.04% 435
2024
Q2 		$58.6M Sell
177,807
-13,662
-7% -$4.83M 0.04% 393
2024
Q1 		$75.8M Buy
191,469
+2,759
+1% +$1.02M 0.05% 376
2023
Q4 		$66.4M Sell
188,710
-7,547
-4% -$2.67M 0.05% 395
2023
Q3 		$73.6M Sell
196,257
-207
-0.1% -$80.1K 0.06% 346
2023
Q2 		$75.1M Sell
196,464
-27,302
-12% -$9.75M 0.06% 358
2023
Q1 		$77.5M Sell
223,766
-71,807
-24% -$21M 0.06% 365
2022
Q4 		$69.6M Sell
295,573
-87,770
-23% -$20.8M 0.06% 397
2022
Q3 		$94.3M Sell
383,343
-62,313
-14% -$19M 0.08% 304
2022
Q2 		$135M Buy
445,656
+9,804
+2% +$3.19M 0.1% 224
2022
Q1 		$179M Sell
435,852
-64,154
-13% -$25.1M 0.12% 185
2021
Q4 		$235M Sell
500,006
-4,275
-0.8% -$1.84M 0.14% 159
2021
Q3 		$214M Sell
504,281
-12,490
-2% -$5.27M 0.13% 169
2021
Q2 		$186M Sell
516,771
-8,599
-2% -$2.84M 0.11% 210
2021
Q1 		$148M Sell
525,370
-1,313
-0.2% -$376K 0.09% 240
2020
Q4 		$149M Buy
526,683
+8,961
+2% +$2.51M 0.1% 230
2020
Q3 		$142M Buy
517,722
+98,139
+23% +$26M 0.1% 226
2020
Q2 		$95.3M Buy
419,583
+55,277
+15% +$10.9M 0.07% 313
2020
Q1 		$55.5M Buy
364,306
+111,000
+44% +$17.1M 0.05% 411
2019
Q4 		$38M Buy
+253,306
New +$36.9M 0.03% 554

Other funds holding WST

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Sumitomo Mitsui Trust Group's WST Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its West Pharmaceutical (WST) stake by 2.7% in Q2 2026, selling an estimated $1.44M and leaving 168,080 shares worth $60.3M. The position accounts for 0.03% of the portfolio, ranked #407.

Sumitomo Mitsui Trust Group first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $235M in Q4 2021. 324 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 168,080 shares of West Pharmaceutical worth $60.3M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 4,700 West Pharmaceutical shares in Q2 2026, an estimated $1.44M.
  • West Pharmaceutical made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #407 holding.
  • Sumitomo Mitsui Trust Group first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Sumitomo Mitsui Trust Group's West Pharmaceutical position peaked at $235M in Q4 2021.
  • 324 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.